Print

DUSA Pharmaceuticals (DUSA) to End Skin Drug Deal With GlaxoSmithKline (GSK)'s Stiefel Laboratories  
10/6/2010 6:18:12 AM

Reuters -- DUSA Pharmaceuticals Inc (DUSA.O) sought to terminate an agreement with a unit of GlaxoSmithKline PLC (GSK.L) to market and distribute its drug to treat scaly patches on the skin, in Latin America.
//-->